Lsl Pharma Group Inc. (LSL)
TSXV
Closed
Oct 8, 2026
Day's Range
0.295052 wk Range
0.2750Overview - LSL - Lsl Pharma Group Inc.
Key Statistics
Valuation
Enterprise Value
87.01M
P/E (Trailing)
‪17.75‬
Price / Sales (TTM)
‪0.89‬
Price / Book
‪1.70‬
EV / EBITDA
‪-53.91‬
Profitability
Gross Margin
‪11.94%‬
Profit Margin
‪-17.53%‬
Operating Margin
‪-7.53%‬
Return on Assets
‪-3.58%‬
Return on Equity
‪-31.63%‬
Ownership
Shares Outstanding
126.72M
Float
95.70M
Held by Insiders
‪24.63%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪-0.52‬
50-Day Avg
‪0.3364‬
200-Day Avg
‪0.3801‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - LSL - Lsl Pharma Group Inc.
Peers - LSL - Lsl Pharma Group Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TSXV.
Profile Summary - LSL - Lsl Pharma Group Inc.
About
Lsl Pharma Group Inc. is a prominent enterprise in the pharmaceutical industry, specializing in the development, manufacturing, and distribution of healthcare products. The company's core mission is to enhance patient health and wellness through innovative pharmaceutical solutions. Lsl Pharma Group Inc. operates…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
